Evidence map›Paper›PMID 23494235›Full record

ArticlePsychopharmacology2013

Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.

Angie M Cason, Gary Aston-Jones

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Associations of COPhysiology & behavior · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Orexin, serotonin, and energy balance.WIREs mechanisms of disease · 2022
    Review
  9. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  10. Review
  11. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System.The international journal of neuropsychopharmacology · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  18. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  19. Orexins, Sleep, and Blood Pressure.Current hypertension reports · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Angie M CasonDepartment of Neurosciences, Medical University of South Carolina, Basic Science Building 406, 173 Ashley Avenue, MSC 510, Charleston, SC 29425, USA.
Gary Aston-Jones
Medical University of South Carolina · US

Funding

ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTIONR01DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 1989 to 2024
$6.0M
Role of Extended Amygdala in Opiate and Cocaine AbuseR37DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 2003 to 2012
$4.2M
Alterations in Reward Processing During Drug AbstinenceR01DA017289 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 2005 to 2009
$1.4M
Drugs of Abuse, Gender Differences, and Protection by SweetsF32DA023354 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CASON, ANGIE · 2008 to 2010
$149k
NIDA NIH HHS DA 017289NIDA NIH HHS DA 023354NIDA NIH HHS DA 06214NIDA NIH HHS F32 DA023354NIDA NIH HHS R01 DA006214NIDA NIH HHS R01 DA017289NIDA NIH HHS R37 DA006214
6 · The paper itself

Abstract

rationaleThe orexin (Orx)/hypocretin system has been implicated in reward-seeking, especially for highly salient food and drug rewards. We recently demonstrated that signaling at the OxR1 receptor is involved in sucrose reinforcement and reinstatement of sucrose-seeking elicited by sucrose-paired cues in food-restricted rats. Because sucrose reinforcement has both a hedonic and caloric component, it remains unknown what aspect of this reward drives its reinforcing value.

objectivesThe present study examined the involvement of the Orx system in operant responding for saccharin, a noncaloric, hedonic (sweet) reward, and in cue-induced reinstatement of extinguished saccharin-seeking in ad libitum-fed vs food-restricted male subjects.

methodsMale Sprague Dawley rats were fed ad libitum or food-restricted and trained to self-administer saccharin. We determined the effects of pretreatment with the OxR1 receptor antagonist SB-334867 (SB; 10-30 mg/kg) on fixed ratio (FR) saccharin self-administration and on cue-induced reinstatement of extinguished saccharin-seeking.

resultsSB decreased responding and number of reinforcers earned during FR responding for saccharin and decreased cue-induced reinstatement of extinguished saccharin-seeking. All of these effects were obtained similarly in food-restricted and ad libitum-fed rats.

conclusionsThese results indicate that signaling at the OxR1 receptor is involved in saccharin reinforcement and reinstatement of saccharin-seeking elicited by saccharin-paired cues regardless of food restriction. These findings lead us to conclude that the Orx system contributes to the motivational effects of hedonic food rewards, independently of caloric value and homeostatic needs.

Indexed as

Orexin Receptor AntagonistsRewardAnimalsBehavior, AnimalBenzoxazolesDose-Response Relationship, DrugDrug-Seeking BehaviorExtinction, PsychologicalFood DeprivationMaleNaphthyridinesRatsRats, Sprague-DawleySaccharinSelf AdministrationUrea1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaBenzoxazolesNaphthyridinesOrexin Receptor AntagonistsSaccharinUrea

Identifiers

PMID23494235
PMCPMC3707982
OpenAlexW2000314222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.